A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Cancer Institute (NCI)
Pfizer
Incyclix Bio
Terremoto Biosciences Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
University of Oklahoma
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Blueprint Medicines Corporation
Case Comprehensive Cancer Center